Literature DB >> 7330811

Investigation of alveolar macrophage function using lucigenin-dependent chemiluminescence.

A J Williams, P J Cole.   

Abstract

The method using lucigenin-dependent phagocytic chemiluminescence is described for the assessment of alveolar macrophage metabolic activity in response to stimulation by opsonised particles or soluble agents. The requirement for superoxide anion (O2-) in the production of chemiluminescence is suggested by inhibition (95%) using superoxide dismutase. The results obtained are correlated with those obtained using another method of detecting O2- release (r = 0.61; p less than 0.05) and are also related by regression analysis to polymorphonuclear leucocyte contamination of the alveolar macrophage suspension. This shows that alveolar macrophages produce lucigenin-dependent chemiluminescence of the same order of magnitude as do polymorphonuclear leucocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7330811      PMCID: PMC471831          DOI: 10.1136/thx.36.11.866

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  Oxygen metabolism in the alveolar macrophage: friend and foe?

Authors:  J Bernard; J B Gee; A S Khandwala
Journal:  J Reticuloendothel Soc       Date:  1976-04

2.  Peroxidase activity of alveolar macrophages.

Authors:  W D Biggar; J M Sturgess
Journal:  Lab Invest       Date:  1976-01       Impact factor: 5.662

3.  Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.

Authors:  R C Allen; L D Loose
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

4.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.

Authors:  P Stevens; D J Winston; K Van Dyke
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

Review 5.  The pulmonary-alveolar macrophage (first of two parts).

Authors:  W G Hocking; D W Golde
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

6.  Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes.

Authors:  R C Allen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

7.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

Review 9.  Oxygen toxicity.

Authors:  L Frank; D Massaro
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

10.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

View more
  7 in total

1.  Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness.

Authors:  C Kelly; C Ward; C S Stenton; G Bird; D J Hendrick; E H Walters
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

2.  Effect of immunoglobulins on mineral dust-induced production of reactive oxygen metabolites by human macrophages.

Authors:  P Nyberg; M Klockars
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

3.  Nedocromil sodium inhibition of IgE-mediated activation of human mononuclear phagocytes and platelets from asthmatics.

Authors:  M Joseph; T Thorel; A Tsicopoulos; A B Tonnel; A Capron
Journal:  Drugs       Date:  1989       Impact factor: 9.546

4.  Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol.

Authors:  A Rudent; F Michel; C Labarre; A M Quero; R Zalisz; P Smets
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  Increased release of free oxygen radicals by phagocytosing and nonphagocytosing cells from patients with active pulmonary sarcoidosis as revealed by luminol-dependent chemiluminescence.

Authors:  J Barth; P Entzian; W Petermann
Journal:  Klin Wochenschr       Date:  1988-04-01

6.  Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases.

Authors:  B Wallaert; F Bart; C Aerts; A Ouaissi; P Y Hatron; A B Tonnel; C Voisin
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

7.  Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity.

Authors:  R W Fuller; P K Morris; R Richmond; D Sykes; I M Varndell; D M Kemeny; P J Cole; C T Dollery; J MacDermot
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.